3'-UTR Polymorphisms in the Vascular Endothelial Growth Factor Gene (VEGF) Contribute to Susceptibility to Recurrent Pregnancy Loss (RPL)

Numerous studies have examined the genetic association of vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs) with recurrent pregnancy loss (RPL). However, of the four known SNPs in the 3'-untranslated region (3'-UTR) of , three SNPs-namely rs3025040 (1451C>...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2019-07, Vol.20 (13), p.3319
Hauptverfasser: An, Hui Jeong, Kim, Ji Hyang, Ahn, Eun Hee, Kim, Young Ran, Kim, Jung Oh, Park, Han Sung, Ryu, Chang Soo, Kim, Eun-Gyo, Cho, Sung Hwan, Lee, Woo Sik, Kim, Nam Keun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Numerous studies have examined the genetic association of vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs) with recurrent pregnancy loss (RPL). However, of the four known SNPs in the 3'-untranslated region (3'-UTR) of , three SNPs-namely rs3025040 (1451C>T), rs10434 (1612G>A), and rs3025053 (1725G>A)-remain poorly characterized with regard to RPL. Herein, we evaluated the association between these three SNPs in the 3'-UTR and RPL susceptibility. We analyzed 3'-UTR gene variants in with and without RPL using TaqMan allelic discrimination. There were significant differences in the genotype frequencies of 1612G>A (GA: adjusted odds ratio (AOR), 0.652; 95% confidence interval (CI), 0.447-0.951; = 0.026) and 1725G>A (GA: AOR, 0.503; 95% CI, 0.229-0.848; = 0.010) in RPL patients vs. controls. Our results indicate that the 1612G>A and 1725G>A polymorphisms in the 3'-UTR of are associated with RPL susceptibility in Korean women. These data suggest that 3'-UTR polymorphisms may be utilized as biomarkers for the detection of RPL risk and prevention.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms20133319